Published Date: 28-Jul-22
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Protein Labeling Market size is expected to reach $3.2 billion by 2028, rising at a market growth of 7.5% CAGR during the forecast period.
The In-vivo segment is showcasing a CAGR of 9.7% during (2022 - 2028). The in-vivo labeling method reveals the continued trafficking of TCF-1+ T cells between tumor and lymphoid tissue. An improved understanding of how immune cells are recruited and maintained in tumors will be required to improve the efficacy of immune checkpoint therapy.
The Reagents segment acquired maximum revenue share in the Global Protein Labeling Market by Product in 2021, thereby, achieving a market value of $2.08 billion by 2028. The growth of the segment is attributed to an increase in the number of labeling agents and genetically modified labels found. Additionally, the commercial availability of effective reagents, such as No-Stain Protein Labeling Reagent, which allows for accurate and reliable protein imaging and normalization, has a beneficial impact on segment growth.
The Cell-based Assays segment has shown growth rate of 7.8% during (2022 - 2028). Cellular assays, also known as cell-based assays, can be utilized to accurately assess the cytotoxicity, biological activity, biochemical processes, and off-target interactions in biomedical research and drug development screening applications. Cell-based assays have the benefit of facilitating the creation of complicated and biologically meaningful data. Cell-based assays, in contrast to standard biochemical assays, are more physiologically important and may examine compound properties simultaneously.
The North America market dominated the Global Protein Labeling Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1.29 billion by 2028. The Europe market is estimated to witness a CAGR of 6.8% during (2022 - 2028). Additionally, The Asia Pacific market would experience a CAGR of 8.4% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/protein-labeling-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Thermo Fisher Scientific, Inc., Merck Group, PerkinElmer, Inc., General Electric (GE) Co., F. Hoffmann-La Roche Ltd., Kaneka Corporation, New England BioLabs Inc., Promega Corporation, LI-COR, Inc., and SeraCare Life Sciences.
Unique Offerings from KBV Research